CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,108,000 | -91.0% | 75,000 | -91.3% | 0.32% | -92.9% |
| Q2 2022 | $23,324,000 | -20.8% | 865,116 | 0.0% | 4.59% | -3.8% |
| Q1 2022 | $29,466,000 | -11.9% | 865,116 | 0.0% | 4.77% | +4.5% |
| Q4 2021 | $33,428,000 | -43.6% | 865,116 | -21.2% | 4.57% | -40.0% |
| Q3 2021 | $59,290,000 | +42.9% | 1,098,174 | -11.5% | 7.62% | +51.3% |
| Q2 2021 | $41,486,000 | +62.3% | 1,240,610 | 0.0% | 5.03% | +81.5% |
| Q1 2021 | $25,557,000 | +82.3% | 1,240,610 | +55.1% | 2.77% | +34.5% |
| Q4 2020 | $14,016,000 | +18.1% | 800,000 | 0.0% | 2.06% | -11.2% |
| Q3 2020 | $11,864,000 | – | 800,000 | – | 2.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,017,524 | $20,961,000 | 7.56% |
| Octagon Capital Advisors LP | 561,398 | $11,565,000 | 4.36% |
| COMMODORE CAPITAL LP | 369,951 | $7,621,000 | 3.04% |
| Opaleye Management Inc. | 985,000 | $20,291,000 | 2.98% |
| VR Adviser, LLC | 1,240,610 | $25,557,000 | 2.77% |
| TSP Capital Management Group, LLC | 359,229 | $7,400,000 | 2.61% |
| RTW INVESTMENTS, LP | 3,908,947 | $80,524,000 | 1.26% |
| Ghost Tree Capital, LLC | 250,000 | $5,150,000 | 1.21% |
| Tri Locum Partners LP | 196,672 | $4,051,000 | 1.00% |
| Redmile Group, LLC | 3,387,788 | $69,788,000 | 0.98% |